Genvio Pharma Limited

Genvio Pharma Limited takes pride in being the specialty company. Understanding the technicality of the industry GENVIO is teaming up Genius through research and entrepreneurs of leadership who can visualize to be counted globally. Genvio believes that quality, safety and effectiveness must be designed and built into the product adhering QbD (Quality by Design) principle. Our state-of-the-art manufacturing facilities designed, built and operated with strict adherence to the current Good Manufacturing Practice (cGMP) to meet and exceed international standards. Technical Collaboration, In-Licensing, Out Licensing, Contract Manufacturing, Merge and Acquisition will be the forefront of the strategies of Genvio Pharma to be prepared for not only Post WTO-TRIPs agreement period, rather will be used from the very beginning for the rapid growth of the company as stated earlier –to be counted globally. Active Pharmaceutical Ingredient (API) production will be another strategy again to be successful to put control over quality from the basic chemicals to finished dosage forms. We are committed to improving patients QoL (Quality of Life) and ensuring all our medicines meet the highest-quality standards and to supply medicines to the patients reliably and quickly. Our Vision is to be the forefront of our industry and to put global footprint as specialty pharmaceutical company through a wide portfolio of Branded and Generic pharmaceutical products. Genvio envisioned to be counted locally as well as universally through organic growth, acquisitions, in-licensing and collaborations. Genvio is committed to making a true difference in patients’ Quality of Life globally through manufacturing utmost quality medicines and maximizing values for our customers and stakeholders. We are focused on earning the leadership in the field of generic pharmaceutical through implementing and translating our plan into action and also by conserving highest ethical values.